Subject
Clinical Biochemistry,General Medicine
Reference14 articles.
1. Biochemical verification of tobacco use and abstinence: 2019 update;Benowitz;Nicotine Tob. Res.,2020
2. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy;Jacob;Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res Cosponsored Am. Soc. Prev. Oncol.,2002
3. Gas chromatographic-mass spectrometric method for determination of anabasine, anatabine and other tobacco alkaloids in urine of smokers and smokeless tobacco users;Jacob;J. Chromatogr.,1993
4. Moyer TP, Charlson JR, Enger RJ, Dale LC, Ebbert JO, Schroeder DR, et al. Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles. Clin. Chem. 2002 Sep;48(9):1460–71.
5. Reference interval determination for anabasine: a biomarker of active tobacco use;Suh-Lailam;J. Anal. Toxicol.,2014
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献